ATRA was used as a comparison, since in APL a rearrangements of the retinoic acid receptor, RARα, makes ATRA highly effective and, in combination with chemotherapy or arsenic trioxide, it is currently used as a model of precision medicine18,25,26. Here, RARA is linked to acute promyelocytic leukemia.